메뉴 건너뛰기




Volumn 80, Issue 4, 2014, Pages 273-274

Erratum: Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes (Anales de Pediatria (2014) 80 (259e1-259e23) DOI: 10.1016/j.anpedi.2013.04.013);Erratun :Prevention of serogroup B meningococcal disease using a four-component vaccine (Anales de Pediatria (2014) 80 (259e1-259e23) DOI: 10.1016/j.anpedi.2013.04.013);Prevention of serogroup B meningococcal disease using a four-component vaccin;Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentese

Author keywords

Meningitis; Meningococcal; Meningococcal vaccines; Prevention and control subheading ; Vaccines

Indexed keywords

4 CMENB VACCINE; BACTERIAL ANTIGEN; FHBP PROTEIN; MENINGOCOCCUS VACCINE; NADA PROTEIN; NHBA PROTEIN; OMVNZ PROTEIN; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG; 4CMENB VACCINE; VACCINE;

EID: 84897448151     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2014.02.015     Document Type: Erratum
Times cited : (3)

References (74)
  • 1
    • 84897416706 scopus 로고    scopus 로고
    • World Health Organization December 2011 [consultado 18 Sep 2012]. Disponible en
    • World Health Organization. Meningococcal meningitis factsheet. December 2011 [consultado 18 Sep 2012]. Disponible en: http://www.who.int/mediacentre/ factsheets/fs141/en/index.html
    • Meningococcal Meningitis Factsheet
  • 2
    • 67349267346 scopus 로고    scopus 로고
    • Global epidemiology of meningococcal disease
    • L.H. Harrison, C.L. Trotter, and M.E. Ramsay Global epidemiology of meningococcal disease Vaccine 27 Suppl 2 2009 B51 B63
    • (2009) Vaccine , vol.27 , Issue.SUPPL. 2
    • Harrison, L.H.1    Trotter, C.L.2    Ramsay, M.E.3
  • 6
    • 77956936981 scopus 로고    scopus 로고
    • Meningococcal disease: The organism, clinical presentation, and worldwide epidemiology
    • J.A. Al-Tawfiq, T.A. Clark, and Z.A. Memish Meningococcal disease: The organism, clinical presentation, and worldwide epidemiology J Travel Med 17 Suppl 2010 3 8
    • (2010) J Travel Med , vol.17 , Issue.SUPPL. , pp. 3-8
    • Al-Tawfiq, J.A.1    Clark, T.A.2    Memish, Z.A.3
  • 7
    • 77951429827 scopus 로고    scopus 로고
    • Advances in the development of vaccines against Neisseria meningitidis
    • L.K. Tan, G.M. Carlone, and R. Borrow Advances in the development of vaccines against Neisseria meningitidis N Engl J Med 362 2010 1511 1520
    • (2010) N Engl J Med , vol.362 , pp. 1511-1520
    • Tan, L.K.1    Carlone, G.M.2    Borrow, R.3
  • 8
    • 84856379848 scopus 로고    scopus 로고
    • Meningococcal vaccines: WHO position paper, November 2011
    • World Health Organization Disponible en
    • World Health Organization Meningococcal vaccines: WHO position paper, November 2011 Weekly epidemiological record. 47 2011 521 540 Disponible en: http://www.who.int/wer/2011/wer8647.pdf
    • (2011) Weekly Epidemiological Record. , vol.47 , pp. 521-540
  • 9
    • 84897377178 scopus 로고    scopus 로고
    • European Centre for Disease Prevention and Control Surveillance reports [consultado Nov 2012]. Disponible en
    • European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe 2008/2009. Surveillance reports [consultado Nov 2012]. Disponible en: http://www.ecdc.europa.eu/en/publications/ Publications/1107-SUR-IBD-2008-09.pdf
    • (2009) Surveillance of Invasive Bacterial Diseases in Europe 2008
  • 10
    • 84897453246 scopus 로고    scopus 로고
    • Ministerio de Salud. Gobierno de Chile. Comenzó vacunación preventiva contra la meningitis en Peñalolén. [consultado Nov 2012]. Disponible en
    • Ministerio de Salud. Gobierno de Chile. Comenzó vacunación preventiva contra la meningitis en Peñalolén. [consultado Nov 2012]. Disponible en: http://www.minsal.gob.cl/portal/url/page/minsalcl/g- noticias/g-visualizacion/noticias-destacadas-6360714.html
  • 12
    • 84892566297 scopus 로고    scopus 로고
    • Centro Nacional de Epidemiología. Instituto Carlos III. Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de información microbiológica. España. Año 2010
    • Servicio de Vigilancia Epidemiológica
    • Servicio de Vigilancia Epidemiológica Centro Nacional de Epidemiología. Instituto Carlos III. Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de información microbiológica. España. Año 2010 Boletín Epidemiológico Semanal 19 2011 100 116
    • (2011) Boletín Epidemiológico Semanal , vol.19 , pp. 100-116
  • 13
    • 79956208618 scopus 로고    scopus 로고
    • Enfermedad meningocócica en España. Análisis de la temporada 2006-2007
    • R. Cano, and M. Garrido Enfermedad meningocócica en España. Análisis de la temporada 2006-2007 Boletín Epidemiológico Semanal 16 2008 73 84
    • (2008) Boletín Epidemiológico Semanal , vol.16 , pp. 73-84
    • Cano, R.1    Garrido, M.2
  • 16
    • 68949175293 scopus 로고    scopus 로고
    • Neisseria meningitidis: Epidemiology, treatment and prevention in adolescents
    • K.S. Brigham, and T.J. Sandora Neisseria meningitidis: Epidemiology, treatment and prevention in adolescents Curr Opin Pediatr 21 2009 437 443
    • (2009) Curr Opin Pediatr , vol.21 , pp. 437-443
    • Brigham, K.S.1    Sandora, T.J.2
  • 17
    • 77954616695 scopus 로고    scopus 로고
    • Management of bacterial meningitis and meningococcal septicaemia in children and young people: Summary of NICE guidance
    • C. Visintin, M.A. Mugglestone, E.J. Fields, P. Jacklin, M.S. Murphy, and A.J. Pollard Management of bacterial meningitis and meningococcal septicaemia in children and young people: Summary of NICE guidance BMJ 340 2010 c3209
    • (2010) BMJ , vol.340 , pp. 3209
    • Visintin, C.1    Mugglestone, M.A.2    Fields, E.J.3    Jacklin, P.4    Murphy, M.S.5    Pollard, A.J.6
  • 18
    • 77951910339 scopus 로고    scopus 로고
    • Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis
    • K. Edmond, A. Clark, V.S. Korczak, C. Sanderson, U.K. Griffiths, and I. Rudan Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis Lancet Infect Dis 10 2010 317 328
    • (2010) Lancet Infect Dis , vol.10 , pp. 317-328
    • Edmond, K.1    Clark, A.2    Korczak, V.S.3    Sanderson, C.4    Griffiths, U.K.5    Rudan, I.6
  • 19
    • 84865145319 scopus 로고    scopus 로고
    • Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): A case-control study
    • R.M. Viner, R. Booy, H. Johnson, W.J. Edmunds, L. Hudson, and H. Bedford et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): A case-control study Lancet Neurol 11 2012 774 783
    • (2012) Lancet Neurol , vol.11 , pp. 774-783
    • Viner, R.M.1    Booy, R.2    Johnson, H.3    Edmunds, W.J.4    Hudson, L.5    Bedford, H.6
  • 21
    • 84883963562 scopus 로고    scopus 로고
    • Department of Health, Victoria, Australia Epidemiology and surveillance [consultado Feb 2012]. Disponible en: ideas.health.vic.gov.au/bluebook/ meningococcal.asp
    • Department of Health, Victoria, Australia. Infectious diseases. Epidemiology and surveillance [consultado Feb 2012]. Disponible en: ideas.health.vic.gov.au/bluebook/meningococcal.asp
    • Infectious Diseases
  • 22
    • 67349185861 scopus 로고    scopus 로고
    • Meningococcal carriage and disease -population biology and evolution
    • D.A. Caugant, and M.C. Maiden Meningococcal carriage and disease -population biology and evolution Vaccine 27 Suppl 2 2009 B64 B70
    • (2009) Vaccine , vol.27 , Issue.SUPPL. 2
    • Caugant, D.A.1    Maiden, M.C.2
  • 23
    • 0037238233 scopus 로고    scopus 로고
    • Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C
    • S. Fernandez, L. Arreaza, I. Santiago, A. Malvar, S. Berron, and J.A. Vazquez et al. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C J Med Microbiol 52 2003 75 77
    • (2003) J Med Microbiol , vol.52 , pp. 75-77
    • Fernandez, S.1    Arreaza, L.2    Santiago, I.3    Malvar, A.4    Berron, S.5    Vazquez, J.A.6
  • 25
    • 0023607404 scopus 로고
    • The Stonehouse survey: Nasopharyngeal carriage of meningococci and Neisseria lactamica
    • K.A. Cartwright, J.M. Stuart, D.M. Jones, and N.D. Noah The Stonehouse survey: Nasopharyngeal carriage of meningococci and Neisseria lactamica Epidemiol Infect 99 1987 591 601
    • (1987) Epidemiol Infect , vol.99 , pp. 591-601
    • Cartwright, K.A.1    Stuart, J.M.2    Jones, D.M.3    Noah, N.D.4
  • 26
    • 0027954586 scopus 로고
    • Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population
    • D.A. Caugant, E.A. Hoiby, P. Magnus, O. Scheel, T. Hoel, and G. Bjune et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population J Clin Microbiol 32 1994 323 330
    • (1994) J Clin Microbiol , vol.32 , pp. 323-330
    • Caugant, D.A.1    Hoiby, E.A.2    Magnus, P.3    Scheel, O.4    Hoel, T.5    Bjune, G.6
  • 28
    • 84857569275 scopus 로고    scopus 로고
    • The systemic inflammatory response syndrome (SIRS), sepsis, and septic shock
    • S.S. Long, L.K. Pickering, C.G. Prober, 3 rd ed. Churchill Livingstone Philadelphia
    • J. Guzman-Cottrill, S. Nadel, and B. Goldstein The systemic inflammatory response syndrome (SIRS), sepsis, and septic shock S.S. Long, L.K. Pickering, C.G. Prober, Principles and practice of pediatric infectious diseases 3 rd ed. 2008 Churchill Livingstone Philadelphia 99 110
    • (2008) Principles and Practice of Pediatric Infectious Diseases , pp. 99-110
    • Guzman-Cottrill, J.1    Nadel, S.2    Goldstein, B.3
  • 29
    • 84897392218 scopus 로고    scopus 로고
    • Neisseria meningitidis
    • S.S. Long, L.K. Pickering, C.G. Prober, 3 rd ed. Churchill Livingstone Elsevier Philadelphia
    • A. Pollard, and A. Finn Neisseria meningitidis S.S. Long, L.K. Pickering, C.G. Prober, Principles and practice of pediatric infectious diseases 3 rd ed. 2008 Churchill Livingstone Elsevier Philadelphia 99 110
    • (2008) Principles and Practice of Pediatric Infectious Diseases , pp. 99-110
    • Pollard, A.1    Finn, A.2
  • 30
    • 77649191024 scopus 로고    scopus 로고
    • Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: A systematic review
    • A. Van den Bruel, T. Haj-Hassan, M. Thompson, F. Buntinx, and D. Mant Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review Lancet 375 2010 834 845
    • (2010) Lancet , vol.375 , pp. 834-845
    • Van Den Bruel, A.1    Haj-Hassan, T.2    Thompson, M.3    Buntinx, F.4    Mant, D.5
  • 31
    • 0033957876 scopus 로고    scopus 로고
    • Update on meningococcal disease with emphasis on pathogenesis and clinical management
    • M. Van Deuren, P. Brandtzaeg, and J.W. van der Meer Update on meningococcal disease with emphasis on pathogenesis and clinical management Clin Microbiol Rev 13 2000 144 166
    • (2000) Clin Microbiol Rev , vol.13 , pp. 144-166
    • Van Deuren, M.1    Brandtzaeg, P.2    Van Der Meer, J.W.3
  • 32
    • 84897416706 scopus 로고    scopus 로고
    • World Health Organization December 2010 [consultado 23 Oct 2010]. Disponible en
    • World Health Organization. Meningococcal meningitis factsheet. December 2010 [consultado 23 Oct 2010]. Disponible en: http://www.who.int/mediacentre/ factsheets/fs141/en/index.html
    • Meningococcal Meningitis Factsheet
  • 34
    • 79958035895 scopus 로고    scopus 로고
    • Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
    • X. Bai, J. Findlow, and R. Borrow Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles Expert Opin Biol Ther 11 2011 969 985
    • (2011) Expert Opin Biol Ther , vol.11 , pp. 969-985
    • Bai, X.1    Findlow, J.2    Borrow, R.3
  • 35
    • 79954802756 scopus 로고    scopus 로고
    • The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease
    • L.H. Harrison, S.I. Pelton, A. Wilder-Smith, J. Holst, M.A. Safadi, and J.A. Vazquez et al. The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease Vaccine 29 2011 3363 3371
    • (2011) Vaccine , vol.29 , pp. 3363-3371
    • Harrison, L.H.1    Pelton, S.I.2    Wilder-Smith, A.3    Holst, J.4    Safadi, M.A.5    Vazquez, J.A.6
  • 36
    • 81355149563 scopus 로고    scopus 로고
    • Epidemiology and prevention of meningococcal disease: A critical appraisal of vaccine policies
    • M.A. Safadi, and E.D. McIntosh Epidemiology and prevention of meningococcal disease: A critical appraisal of vaccine policies Expert Rev Vaccines. 10 2011 1717 1730
    • (2011) Expert Rev Vaccines. , vol.10 , pp. 1717-1730
    • Safadi, M.A.1    McIntosh, E.D.2
  • 37
    • 85046979879 scopus 로고    scopus 로고
    • Meningococcal disease: The advances and challenges of meningococcal disease prevention
    • R. Yogev, and T. Tan Meningococcal disease: The advances and challenges of meningococcal disease prevention Hum Vaccin 7 2011 828 837
    • (2011) Hum Vaccin , vol.7 , pp. 828-837
    • Yogev, R.1    Tan, T.2
  • 38
    • 80053960664 scopus 로고    scopus 로고
    • Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century
    • P. Kriz, H. Wieffer, K. Holl, M. Rosenlund, S. Budhia, and A. Vyse Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century Expert Rev Vaccines 10 2011 1477 1486
    • (2011) Expert Rev Vaccines , vol.10 , pp. 1477-1486
    • Kriz, P.1    Wieffer, H.2    Holl, K.3    Rosenlund, M.4    Budhia, S.5    Vyse, A.6
  • 39
    • 33644840604 scopus 로고    scopus 로고
    • Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands
    • S.C. De Greeff, H.E. de Melker, L. Spanjaard, L.M. Schouls, and A. van Derende Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands Pediatr Infect Dis J 25 2006 79 80
    • (2006) Pediatr Infect Dis J , vol.25 , pp. 79-80
    • De Greeff, S.C.1    De Melker, H.E.2    Spanjaard, L.3    Schouls, L.M.4    Van Derende, A.5
  • 40
    • 20444437173 scopus 로고    scopus 로고
    • Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain
    • A. Larrauri, R. Cano, M. Garcia, and S. Mateo Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain Vaccine 23 2005 4097 4100
    • (2005) Vaccine , vol.23 , pp. 4097-4100
    • Larrauri, A.1    Cano, R.2    Garcia, M.3    Mateo, S.4
  • 41
    • 84897442959 scopus 로고    scopus 로고
    • Grupo de trabajo de enfermedad meningocócica de la ponencia de programa y registro de vacunación
    • Modificación de la pauta de vacunación frente meningitis C. Ministerio de Sanidad y Consumo
    • Grupo de trabajo de enfermedad meningocócica de la ponencia de programa y registro de vacunación. Situación actual de la enfermedad meningocócica en España. Modificación de la pauta de vacunación frente meningitis C. Ministerio de Sanidad y Consumo, 2005.
    • (2005) Situación Actual de la Enfermedad Meningocócica en España
  • 42
    • 79956208618 scopus 로고    scopus 로고
    • Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Enfermedad meningocócica en España. Análisis de la temporada 2006-2007
    • R. Cano, and M. Garrido Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Enfermedad meningocócica en España. Análisis de la temporada 2006-2007 Bol Epidemiol Sem 16 2008 73 76
    • (2008) Bol Epidemiol Sem , vol.16 , pp. 73-76
    • Cano, R.1    Garrido, M.2
  • 43
    • 84856726207 scopus 로고    scopus 로고
    • Microbiology and public health: New challenges in surveillance and control of meningococcal disease
    • R. Abad, and J.A. Vazquez Microbiology and public health: new challenges in surveillance and control of meningococcal disease Enferm Infecc Microbiol Clin 30 2012 53 55
    • (2012) Enferm Infecc Microbiol Clin , vol.30 , pp. 53-55
    • Abad, R.1    Vazquez, J.A.2
  • 44
    • 80053490173 scopus 로고    scopus 로고
    • Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza
    • N. Principi, and S. Esposito Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza Hum Vaccin 7 2011 905 912
    • (2011) Hum Vaccin , vol.7 , pp. 905-912
    • Principi, N.1    Esposito, S.2
  • 45
    • 3042678850 scopus 로고    scopus 로고
    • Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain
    • B. Alcala, C. Salcedo, L. Arreaza, R. Abad, R. Enriquez, and L. De La Fuente et al. Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain J Med Microbiol 53 2004 515 518
    • (2004) J Med Microbiol , vol.53 , pp. 515-518
    • Alcala, B.1    Salcedo, C.2    Arreaza, L.3    Abad, R.4    Enriquez, R.5    De La Fuente, L.6
  • 46
    • 79957583774 scopus 로고    scopus 로고
    • A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease
    • E.L. Su, and M.D. Snape A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease Expert Rev Vaccines 10 2011 575 588
    • (2011) Expert Rev Vaccines , vol.10 , pp. 575-588
    • Su, E.L.1    Snape, M.D.2
  • 47
    • 63249115447 scopus 로고    scopus 로고
    • Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease
    • J. O'Hallahan, A. McNicholas, Y. Galloway, E. O'Leary, and C. Roseveare Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease N Z Med J 122 2009 48 59
    • (2009) N Z Med J , vol.122 , pp. 48-59
    • O'Hallahan, J.1    McNicholas, A.2    Galloway, Y.3    O'Leary, E.4    Roseveare, C.5
  • 48
    • 34247890242 scopus 로고    scopus 로고
    • Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005
    • P. Rouaud, A. Perrocheau, M.K. Taha, C. Sesboue, A.M. Forgues, and I. Parent du Chatelet et al. Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005 Euro Surveill 11 2006 178 181
    • (2006) Euro Surveill , vol.11 , pp. 178-181
    • Rouaud, P.1    Perrocheau, A.2    Taha, M.K.3    Sesboue, C.4    Forgues, A.M.5    Parent Du Chatelet, I.6
  • 50
    • 77957941966 scopus 로고    scopus 로고
    • Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: A randomized comparative trial
    • M.D. Snape, T. Dawson, P. Oster, A. Evans, T.M. John, and B. Ohene-Kena et al. Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: A randomized comparative trial Pediatr Infect Dis J 29 2010 e71 e79
    • (2010) Pediatr Infect Dis J , vol.29
    • Snape, M.D.1    Dawson, T.2    Oster, P.3    Evans, A.4    John, T.M.5    Ohene-Kena, B.6
  • 51
    • 0028147943 scopus 로고
    • Sero/subtyping of Neisseria meningitidis isolated from patients in Spain
    • J.A. Vazquez, C. Marcos, and S. Berron Sero/subtyping of Neisseria meningitidis isolated from patients in Spain Epidemiol Infect 113 1994 267 274
    • (1994) Epidemiol Infect , vol.113 , pp. 267-274
    • Vazquez, J.A.1    Marcos, C.2    Berron, S.3
  • 53
    • 84864147338 scopus 로고    scopus 로고
    • Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial
    • P.C. Richmond, H.S. Marshall, M.D. Nissen, Q. Jiang, K.U. Jansen, and M. Garces-Sanchez et al. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial Lancet Infect Dis 12 2012 597 607
    • (2012) Lancet Infect Dis , vol.12 , pp. 597-607
    • Richmond, P.C.1    Marshall, H.S.2    Nissen, M.D.3    Jiang, Q.4    Jansen, K.U.5    Garces-Sanchez, M.6
  • 54
    • 77955516093 scopus 로고    scopus 로고
    • Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
    • H.Q. Jiang, S.K. Hoiseth, S.L. Harris, L.K. McNeil, D. Zhu, and C. Tan et al. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease Vaccine 28 2010 6086 6093
    • (2010) Vaccine , vol.28 , pp. 6086-6093
    • Jiang, H.Q.1    Hoiseth, S.K.2    Harris, S.L.3    McNeil, L.K.4    Zhu, D.5    Tan, C.6
  • 55
    • 4544303750 scopus 로고    scopus 로고
    • Biotechnology and vaccines: Application of functional genomics to Neisseria meningitidis and other bacterial pathogens
    • D. Serruto, J. Adu-Bobie, B. Capecchi, R. Rappuoli, M. Pizza, and V. Masignani Biotechnology and vaccines: Application of functional genomics to Neisseria meningitidis and other bacterial pathogens J Biotechnol 113 2004 15 32
    • (2004) J Biotechnol , vol.113 , pp. 15-32
    • Serruto, D.1    Adu-Bobie, J.2    Capecchi, B.3    Rappuoli, R.4    Pizza, M.5    Masignani, V.6
  • 56
    • 0035925596 scopus 로고    scopus 로고
    • Reverse vaccinology, a genome-based approach to vaccine development
    • R. Rappuoli Reverse vaccinology, a genome-based approach to vaccine development Vaccine 19 2001 2688 2691
    • (2001) Vaccine , vol.19 , pp. 2688-2691
    • Rappuoli, R.1
  • 58
    • 0034629284 scopus 로고    scopus 로고
    • Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
    • M. Pizza, V. Scarlato, V. Masignani, M.M. Giuliani, B. Arico, and M. Comanducci et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 2000 1816 1820
    • (2000) Science , vol.287 , pp. 1816-1820
    • Pizza, M.1    Scarlato, V.2    Masignani, V.3    Giuliani, M.M.4    Arico, B.5    Comanducci, M.6
  • 59
    • 84867397072 scopus 로고    scopus 로고
    • Developing vaccines in the era of genomics: A decade of reverse vaccinology
    • K.L. Seib, X. Zhao, and R. Rappuoli Developing vaccines in the era of genomics: A decade of reverse vaccinology Clin Microbiol Infect 18 Suppl 5 2012 109 116
    • (2012) Clin Microbiol Infect , vol.18 , Issue.SUPPL. 5 , pp. 109-116
    • Seib, K.L.1    Zhao, X.2    Rappuoli, R.3
  • 61
    • 79960790578 scopus 로고    scopus 로고
    • Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults
    • D. Toneatto, P. Oster, A.C. deBoer, A. Emerson, G.F. Santos, and E. Ypma et al. Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults Hum Vaccin 7 2011 781 791
    • (2011) Hum Vaccin , vol.7 , pp. 781-791
    • Toneatto, D.1    Oster, P.2    Deboer, A.C.3    Emerson, A.4    Santos, G.F.5    Ypma, E.6
  • 62
    • 14844296966 scopus 로고    scopus 로고
    • MeNZB: A safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
    • P. Oster, D. Lennon, J. O'Hallahan, K. Mulholland, S. Reid, and D. Martin MeNZB: A safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain Vaccine 23 2005 2191 2196
    • (2005) Vaccine , vol.23 , pp. 2191-2196
    • Oster, P.1    Lennon, D.2    O'Hallahan, J.3    Mulholland, K.4    Reid, S.5    Martin, D.6
  • 63
    • 78349257850 scopus 로고    scopus 로고
    • Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy
    • J. Findlow, R. Borrow, M.D. Snape, T. Dawson, A. Holland, and T.M. John et al. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy Clin Infect Dis 51 2010 1127 1137
    • (2010) Clin Infect Dis , vol.51 , pp. 1127-1137
    • Findlow, J.1    Borrow, R.2    Snape, M.D.3    Dawson, T.4    Holland, A.5    John, T.M.6
  • 65
    • 84897454266 scopus 로고    scopus 로고
    • Persistence of bactericidal antibodies following early infant immunisation with serogroup B meningococcal vaccines and immunogenicity of pre-school booster doses - A follow-on study
    • Thessaloniki, Greece. 8-11 Poster No 664. Disponible en
    • P. Saroey, M.D. Snape, T.M. John, H. Robinson, S. Kelly, and N. Gossger et al. Persistence of bactericidal antibodies following early infant immunisation with serogroup B meningococcal vaccines and immunogenicity of pre-school booster doses - a follow-on study Poster presented at the European Society for Paediatric Infectious Diseases (ESPID) annual meeting Thessaloniki, Greece. 8-11 2012 Poster No 664. Disponible en: www.kenes.com/espid2012/ abstracts/
    • (2012) Poster Presented at the European Society for Paediatric Infectious Diseases (ESPID) Annual Meeting
    • Saroey, P.1    Snape, M.D.2    John, T.M.3    Robinson, H.4    Kelly, S.5    Gossger, N.6
  • 66
    • 84856773073 scopus 로고    scopus 로고
    • Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial
    • N. Gossger, M.D. Snape, L.M. Yu, A. Finn, G. Bona, and S. Esposito et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial JAMA 307 2012 573 582
    • (2012) JAMA , vol.307 , pp. 573-582
    • Gossger, N.1    Snape, M.D.2    Yu, L.M.3    Finn, A.4    Bona, G.5    Esposito, S.6
  • 67
    • 79957593818 scopus 로고    scopus 로고
    • Immunogenicity of an investigational, multicomponent, meningococcall serogroup B vaccine in healthy infants at 2, 4, and 6 months of age
    • Banff, Canada, Sept 11-16 Poster No 180. Disponibleen
    • T. Vesikari, S. Esposito, A. Kimura, A. Kleinschmidt, E. Ypma, and D. Toneatto et al. Immunogenicity of an investigational, multicomponent, meningococcall serogroup B vaccine in healthy infants at 2, 4, and 6 months of age Presented at: International Pathogenic Neisseria Conference Banff, Canada, Sept 11-16 2010 Poster No 180. Disponible en: http://neisseria.org/ipnc/2010/ IPNC-2010
    • (2010) Presented At: International Pathogenic Neisseria Conference
    • Vesikari, T.1    Esposito, S.2    Kimura, A.3    Kleinschmidt, A.4    Ypma, E.5    Toneatto, D.6
  • 68
    • 84855585556 scopus 로고    scopus 로고
    • Tolerability of a three-dose schedule of an investigational, multicomponent, meningococcal serogroup B vaccine and routine infant vaccines in a lot consistency trial
    • Banff, Canada, Sept 11-16 Poster No 182. Disponible en
    • S. Esposito, T. Vesikari, A. Kimura, E. Ypma, D. Toneatto, and P. Dull Tolerability of a three-dose schedule of an investigational, multicomponent, meningococcal serogroup B vaccine and routine infant vaccines in a lot consistency trial Presented at International Pathogenic Neisseria Conference Banff, Canada, Sept 11-16 2010 Poster No 182. Disponible en: http://neisseria.org/ipnc/2010/IPNC-2010
    • (2010) Presented at International Pathogenic Neisseria Conference
    • Esposito, S.1    Vesikari, T.2    Kimura, A.3    Ypma, E.4    Toneatto, D.5    Dull, P.6
  • 69
    • 84897436490 scopus 로고    scopus 로고
    • Catch-up vaccination of healthy toddlers with an investigational multicomponent meningococcal serogroup b vaccine (4 cmenb) - Exploration of a two-dose schedule
    • The Hague, The Netherlands, June 7-11 Poster No 706. Disponible en
    • R. Prymula, T. Vesikari, T. Esposito, I. Kohl, E. Ypma, and D. Toneatto et al. Catch-up vaccination of healthy toddlers with an investigational multicomponent meningococcal serogroup b vaccine (4 cmenb) - exploration of a two-dose schedule Present at 29th ESPID Meeting The Hague, The Netherlands, June 7-11 2011 Poster No 706. Disponible en: www.kenes.com/espid2011/cd/
    • (2011) Present at 29th ESPID Meeting
    • Prymula, R.1    Vesikari, T.2    Esposito, T.3    Kohl, I.4    Ypma, E.5    Toneatto, D.6
  • 70
    • 84857238470 scopus 로고    scopus 로고
    • Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4 CMenB) vaccine in healthy adolescents in Chile: A phase 2b/3 randomised, observer-blind, placebo-controlled study
    • M.E. Santolaya, M.L. O'Ryan, M.T. Valenzuela, V. Prado, R. Vergara, and A. Munoz et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4 CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study Lancet 379 2012 617 624
    • (2012) Lancet , vol.379 , pp. 617-624
    • Santolaya, M.E.1    O'Ryan, M.L.2    Valenzuela, M.T.3    Prado, V.4    Vergara, R.5    Munoz, A.6
  • 71
    • 78650604587 scopus 로고    scopus 로고
    • Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
    • J. Donnelly, D. Medini, G. Boccadifuoco, A. Biolchi, J. Ward, and C. Frasch et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines Proc Natl Acad Sci U S A 107 2010 19490 19495
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 19490-19495
    • Donnelly, J.1    Medini, D.2    Boccadifuoco, G.3    Biolchi, A.4    Ward, J.5    Frasch, C.6
  • 72
    • 84867281306 scopus 로고    scopus 로고
    • Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines
    • B.D. Plikaytis, M. Stella, G. Boccadifuoco, L.M. Detora, M. Agnusdei, and L. Santini et al. Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines Clin Vaccine Immunol 19 2012 1609 1617
    • (2012) Clin Vaccine Immunol , vol.19 , pp. 1609-1617
    • Plikaytis, B.D.1    Stella, M.2    Boccadifuoco, G.3    Detora, L.M.4    Agnusdei, M.5    Santini, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.